LifeStance Health (LFST) Enterprise Value (2021 - 2026)

LifeStance Health (LFST) has reported Enterprise Value for 7 consecutive years, with -$76.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value fell 1.33% year-over-year to -$76.9 million; the TTM figure through Mar 2026 stood at -$76.9 million (down 1.33% YoY), while the FY2025 annual figure was -$248.6 million, down 105.68% from the prior year.
• Enterprise Value climbed to -$76.9 million in Q1 2026 per LFST's latest filing, from -$248.6 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$28.5 million in Q3 2023 and bottomed at -$248.6 million in Q4 2025.
• Historically, Enterprise Value has averaged -$101.9 million across 5 years, with a median of -$87.0 million in 2024.
• Annual changes were most pronounced in 2023 — Enterprise Value jumped 68.47% — and 2024, when it sank 205.07%.
• LifeStance Health's Enterprise Value stood at -$108.6 million in 2022, then jumped by 37.68% to -$67.7 million in 2023, then tumbled by 78.57% to -$120.9 million in 2024, then tumbled by 105.68% to -$248.6 million in 2025, then surged by 69.06% to -$76.9 million in 2026.
• Business Quant data shows LFST's Enterprise Value at -$76.9 million in Q1 2026, -$248.6 million in Q4 2025, and -$203.9 million in Q3 2025.